🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

7 recruiting trials

for Neuroblastoma (NB)

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma NCT06057948Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: OPT-821 (QS-21), oral β-glucan Safety, Tolerability, and Preliminary Efficacy of [211At]MABG in Patients With Relapsed or Refractory Neuroblastoma NCT07767630EARLY Phase 11 site📍 Chengdu Sichuan University · Tests: [211At]MABG Phase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in Children NCT07318831Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Chidamide Combined with Dinutuximab Beta, Irinotecan, and Temozolomide Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma NCT07375563Phase 31 site📍 Moscow Federal Research Institute of Pediatric Hematology, Oncolog… · Tests: Dinutuximab beta, temozolomide, irinotecan, autologous NK cell, irinotecan, temozolomide, dinutuximab beta, NK-cell pro… Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial. NCT06836505Phase 1, Phase 23 sites📍 Guangzhou📍 Dongguan📍 Shanghai Sun Yat-Sen University Cancer Center · Tests: CART therapy Safety and Efficacy of Systemic Allogenic NK Cells in R/R Neuroblastoma NCT06674265Phase 11 site📍 Tehran Marzieh Ebrahimi · Tests: Allogenic NK cells infusion Clinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the Diagnosis and Staging of Neuroblastoma NCT07064746n/a1 site📍 Nanjing Nanjing First Hospital, Nanjing Medical University · Tests: ¹²³I-MIBG SPECT/CT, SSTR PET
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy